1. Home
  2. KRNY vs SLDB Comparison

KRNY vs SLDB Comparison

Compare KRNY & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRNY
  • SLDB
  • Stock Information
  • Founded
  • KRNY 1884
  • SLDB 2013
  • Country
  • KRNY United States
  • SLDB United States
  • Employees
  • KRNY N/A
  • SLDB N/A
  • Industry
  • KRNY Savings Institutions
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • KRNY Finance
  • SLDB Health Care
  • Exchange
  • KRNY Nasdaq
  • SLDB Nasdaq
  • Market Cap
  • KRNY 450.4M
  • SLDB 366.2M
  • IPO Year
  • KRNY 2005
  • SLDB 2018
  • Fundamental
  • Price
  • KRNY $6.35
  • SLDB $3.69
  • Analyst Decision
  • KRNY Buy
  • SLDB Strong Buy
  • Analyst Count
  • KRNY 2
  • SLDB 10
  • Target Price
  • KRNY $7.75
  • SLDB $18.10
  • AVG Volume (30 Days)
  • KRNY 322.5K
  • SLDB 1.2M
  • Earning Date
  • KRNY 04-24-2025
  • SLDB 03-06-2025
  • Dividend Yield
  • KRNY 7.03%
  • SLDB N/A
  • EPS Growth
  • KRNY N/A
  • SLDB N/A
  • EPS
  • KRNY N/A
  • SLDB N/A
  • Revenue
  • KRNY $148,070,000.00
  • SLDB N/A
  • Revenue This Year
  • KRNY $2.70
  • SLDB N/A
  • Revenue Next Year
  • KRNY $24.88
  • SLDB $717.65
  • P/E Ratio
  • KRNY N/A
  • SLDB N/A
  • Revenue Growth
  • KRNY N/A
  • SLDB N/A
  • 52 Week Low
  • KRNY $5.28
  • SLDB $2.88
  • 52 Week High
  • KRNY $8.59
  • SLDB $12.95
  • Technical
  • Relative Strength Index (RSI)
  • KRNY 43.22
  • SLDB 37.14
  • Support Level
  • KRNY $6.29
  • SLDB $4.12
  • Resistance Level
  • KRNY $6.58
  • SLDB $4.44
  • Average True Range (ATR)
  • KRNY 0.16
  • SLDB 0.37
  • MACD
  • KRNY 0.01
  • SLDB -0.19
  • Stochastic Oscillator
  • KRNY 45.24
  • SLDB 20.98

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. It is also heavily into secured and unsecured business and consumer loans. The bank's primary source of income is net interest income.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

Share on Social Networks: